Lisa Arkin, MD
Assistant Professor and Director of Pediatric Dermatology
University of Wisconsin-Madison
MedGames is a comprehensive and interactive gamification-based CME activity that presents important continuing education topics in a fun and engaging manner. This MedGames activity covers important and need-to-know topics related to the assessment and management of moderate-to-severe atopic dermatitis, with a special focus on Janus kinase (JAK) inhibitors. Participants in this MedGames activity will learn about the assessment of atopic dermatitis severity, determining the need for step-up therapy, and the latest safety and efficacy data from clinical trials for the use of JAK inhibitors in patients with moderate-to-severe atopic dermatitis. In addition, participants will learn how to advise patients with atopic dermatitis on vaccination against SARS-CoV-2 based on guidance from the Centers for Disease Control and Prevention and leading medical societies. This program is hosted by Ken Jennings, the new host of a popular game show, and is presented by Lisa Arkin, MD, Associate Professor and Director of Pediatric Dermatology at the University of Wisconsin-Madison.features the diagnosis, treatment, and management of NTM-LD.
This educational activity is intended for dermatologists, allergists, and other healthcare providers who are involved in the care and treatment of patients with moderate-to-severe atopic dermatitis.
Upon the completion of this program, attendees should be able to:
- Assess the severity of atopic dermatitis and identify patients with moderate-to-severe disease who require step-up therapy
- Utilize emerging clinical trial data to evaluate the benefits and risks of JAK inhibitors for the management of moderate-to-severe atopic dermatitis
- Incorporate updated recommendations on vaccination against SARS-CoV-2 and guidance on the management of atopic dermatitis during the COVID-19 pandemic into clinical practice
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSING CREDIT INFORMATION
Purpose: Education regarding the management of atopic dermatitis leads to safe practices, quality care, and continued professional and personal development for nurses. CNE Credits: 1.0 ANCC Contact Hour.
CNE Accreditation Statement: Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
Lisa Arkin, MD reports that she is a consultant for Regeneron and AbbVie and serves as a principal investigator for Amgen and Candela (use of equipment).
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner
The reviewer of this activity has nothing to disclose
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Andrew D. Bowser, ELS, CHCP, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Ashley Whitehurst, Program Manager for Med Learning Group, has nothing to disclose.
Russie Allen, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
Natalie Smith, Program Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this activity. To receive CME/CNE credit participants must:
- Read the CME/CNE information and faculty disclosures.
- Participate in the activity.
- Complete pre-and-post surveys and evaluation.
You will receive your certificate as a downloadable file.
Med Learning Group makes every effort to develop CME activities that are science based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at email@example.com. Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at firstname.lastname@example.org
Copyright © 2021 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.